Author:
Braun G.,Kalbhen D. A.,Müller J.,Vahar -Matiar H.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health
Reference34 articles.
1. Abramson, H. A., Jarvik, M. E., Gorin, M. H., Hirsch, M. W.: Lysergic acid diethylamide (LSD-25) tolerance development and its relationship to a theory of Psychosis. J. Psychol.41, 81 (1956)
2. Abramson, H. A., Sklarofsky, B., Baron, M. O., Fremont-Smith, N.: Lysergic acid Diethylamide (LSD-25) antagonist. II. Development of tolerance in man to LSD-25 by prior administration of MLD 41 (1-methyl-d-lysergic acid diethylamide). Arch. Neurol. Psychiat. (Chic.)79, 201 (1958)
3. Arnold, O.: Correlation between biochemical and clinical data in schizophrenics. In: O. Wallace: Molecular basis of some aspects of mental activity. London: Acad. Press 1967
4. Balestrieri, A., Fontanari, D.: Acquired and crossed tolerance to mescaline, LSD-25 and BOL-148. Arch. Psychiat. (Chic.)1, 279 (1959)
5. Balestrieri, A.: Crossed tolerance between LSD-25 and mescalin: In: Garattini and Ghetti: Psychotropic drugs. New York: Van Nordstrand 1957